Debra A . Wong, M.D.

(877) 460-4673
Debra Wong
Medical Oncologist
Clinical Expertise
Genitourinary Cancers
Cutaneous Malignancies
Sarcoma
Gynecologic Cancers
Palliative Care
Research Area
Patient-centered Outcomes
Supportive Care in Oncology
Innovation to Improve Access to Quality Care
Telemedicine
Value-based Care
Appointments
Medical Director, AccessHope™
Assistant Professor, Department of Medical Oncology & Therapeutics Research
Clinical Teams
Medical Oncology & Therapeutics Research
Urologic Cancers
Research Teams
AccessHope
Medical Oncology & Therapeutics Research
Debra A. Wong, M.D., is a board-certified medical oncologist and medical director for AccessHopeTM, where she leads organizational development and integration of clinical strategy. She maintains broad expertise in solid tumor oncology and advocates for integrating supportive care and quality-of-life measures into precision oncology care. For her humanity and whole-person approach, she has earned recognition among peers and patients alike.
 
Always embracing innovation, Dr. Wong helps lead City of Hope and AccessHope in democratizing value-based, quality-driven oncology care, so those with cancer can seamlessly access expert insights likely to improve their outcomes, without leaving home and their local support system. Dr. Wong is excited to further develop novel technology-enhanced care delivery systems that improve the patient and caregiver experience, working with clinical partners and the health technology sector to broaden the scope of supportive care resources.
 
Dr. Wong is a diplomate of the American Board of Internal Medicine with board certifications in medical oncology, hospice and palliative medicine, and internal medicine. She completed her fellowship in hematology and medical oncology at Mayo Clinic , following a fellowship in hospice and palliative medicine at Cedars-Sinai Medical Center and the West Los Angeles Veterans Affairs Medical Center. She completed her residency in internal medicine at Cedars-Sinai Medical Center. Dr. Wong earned her medical degree at the Royal College of Surgeons in Ireland and is a licentiate of the Royal College of Physicians and Surgeons.

Location

Education & Experience

Board Certifications

  • Medical Oncology, American Board of Internal Medicine

  • Hospice and Palliative Medicine, American Board of Internal Medicine

  • Internal Medicine, American Board of Internal Medicine

Degrees

  • M.B., B.C.h., B.A.O., M.D., Royal College of Surgeons in Ireland, Dublin, Ireland

Fellowship

  • Hematology/Oncology, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Scottsdale, AZ

  • Hospice & Palliative Medicine, Cedars-Sinai Medical Center/West Los Angeles VA Medical Center, Los Angeles, CA

Residency

  • Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

Internship

  • Internal Medicine, St. Elizabeth's Medical Center, Boston, MA

Professional Experience

  • 2022-present, VP of Development & Integration of Clinical Strategy, AccessHope™, Duarte, CA

  • 2020-present, Medical Director, AccessHope™, Duarte, CA

  • 2020-present, Assistant Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

  • 2018-2020, Site Director of Oncology, Hospice and Palliative Medicine Fellowship Program, Creighton University School of Medicine, St. Joseph's Hospital and Medical Center and University of Arizona Cancer Center, Phoenix, AZ

  • 2017-2020, Clinical Assistant Professor, Department of Interdisciplinary Oncology and Department of Internal Medicine, Creighton University & University of Arizona College of Medicine, Phoenix, AZ

  • 2017-2020, Faculty Medical Oncologist, University of Arizona Cancer Center at Dignity Health, St. Joseph’s Hospital & Medical Center, Phoenix, AZ

  • 2016, Consultant Medical Oncologist, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ

Awards & Memberships

Awards

  • 2018, 2017, Top Doctor in Phoenix, Arizona, International Association of Oncologists, International Association of Healthcare Professionals

  • 2016, Scholarship Recipient, Appendix Cancer/Pseudomyxoma Peritonei Research Foundation

  • 2013, VIP Recognition Award in Palliative Care - Department of Veterans Affairs, West Los Angeles Healthcare Center

  • 2012, Ben Newman, MD Humanism Award, Cedars-Sinai Medical Center

Memberships

  • American Society of Clinical Oncology

  • American College of Physicians

Publications

  • West HJ, Barzi A, Wong DA. Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0? Curr Oncol Rep 24:1843-1850, 2022.
  • West H, Tan AY, Barzi A, Wong DA, Parsley R, Sachs T. A novel program offering remote, asynchronous subspecialist input in thoracic oncology and other cancers: early experience gained during the COVID-19 pandemic. JCO Oncol Pract 18: e537-e550, 2022.
  • Duong T*, Wong D, Barrett A, et al. Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. BMJ Case Rep. 2021;14:e238966
  • Tjitro A,* Wong DA, Ajmal A, et al. Virilization by an ovarian tumor: presentation is not always acute. J Clin Trans Endocrinol Case Rep.10: 23247096211056494, 2022.
  • Wong T, Wong DA, Ayaad H, et al. Small bowel intussusception secondary to metastatic spindle cell sarcoma: A case report and review of the literature. Open Acc J Oncol Med 2020;3(3):269-75.
  • Wang T, Marsh S, Ding Z, Boddupalli S-S, Wong DA, Wang J. Overcoming chemotherapy resistance by targeting the insulin-like growth factor 1 (IGF-1) axis in a patient with metastatic castration-resistant prostate cancer and pituitary adenoma: Killing two birds with one stone. J Clin Trials Pathol Case Stud 2018;2(2):70-4.
  • Go VL, Wong DA, Wang Y, Butrum RR, Norman HA, Wilkerson L. Diet and cancer prevention: evidence-based medicine to genomic medicine. J Nutr. 2004 Dec; 134(12 Suppl):3513S-3516S. PMID:15570062
  • Go VL, Butrum RR, Wong DA. Diet, nutrition, and cancer prevention: the postgenomic era. J Nutr. 2003 Nov; 133(11 Suppl 1):3830S-3836S. PMID:14608122
  • Go VL, Wong DA. Butrum R. Diet, nutrition and cancer prevention: where are we going from here? J Nutr. 2001 Nov; 131(11 Suppl):3121S-6S. PMID:11694657
  • Go VL, Wong DA, Resnick MS, Heber D. Evaluation of botanicals and dietary supplements therapy in cancer patients. J Nutr. 2001 Jan; 131(1):179S-180S. PMID:11208960

Abstracts

  • Wong DA, Magtibay P, Wasif N, Karlin N. A novel application of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) in early-stage mucinous ovarian cancer. Journal of the Peritoneum 2016;1:(S1)78-9.
  • Wong D, Ernst B, Northfelt D, Fitch T, Arceci R, Camoriano J. Neurodegenerative Langerhans cell histiocytosis: Are pediatric therapies effective in the adult population? Pediatric Blood & Cancer 2016 Nov; 63 (Suppl 2):S36.
  • Wong DA, Curtis K, Carballido E, McCue N, Bryce A, Larson M, Halfdanarson T. Psychosocial supportive services in the routine oncologic care of young adults with cancer. Abstract and poster presented at the American Academy of Hospice and Palliative Medicine Annual Assembly, Philadelphia, PA. 2015 Feb 02.
  • Wong DA, Fitch TR, Prommer E, Chang Y-H, Lipinski CA. Developing a new model of care for patients with cancer who present to the emergency department: the Mayo Clinic Experience. J Clin Oncol. 2014; 32(Suppl 31):Abstr 61.
  • Bharadwaj P, Wong DA, Sharma I, Park JY, Lopez AM. Patient-controlled anxiolytic: a novel PCA. Abstract and poster presented at the American Academy of Hospice and Palliative Medicine Annual Assembly, New Orleans, LA. 2013 March 13-16.
  • Wong DA, Steinberg AS, Bresee C, Lopez AM, Lim S, Lill M. TLI-ATG for nonmyeloablative stem cell transplant: a single center experience (abstract 6578). J Clin Oncol. 2011; 29(15S):438S.

Book Chapters

  • Karlin N, Wong DA. Breast lymphoma and mesenchymal neoplasms of the breast. In: Bland K, Copeland E, Klimberg S, Gradishar W. The Breast: Comprehensive Management of Benign and Malignant Diseases 6th ed. Philadelphia, PA: Elsevier; 2016.
  • Yip I, Wong DA, Go VLW. Complementary medicine for treatment of prostate cancer. In: Lucas JN. Progress in Prostate Cancer Research Hauppauge, NY: Nova Science Publishers, Inc.; 2005. p. 47-72.